Scotiaderm receives funding and support through CABHI’s Fuel program!

The Centre for Aging + Brain Health Innovation (CABHI), powered by Baycrest, just announced
$2.8 million CAD in funding to eight researchers and companies through its Fuel program, including Scotiaderm.
Through Fuel, innovators gain access to funding and CABHI’s Acceleration Services to streamline their innovation journey and pathway to market.

CABHI’s Fuel program supports early- to mid-stage researchers and companies in achieving
milestones related to research and development, product testing, and validation. Beyond
financial support, innovators benefit from a tailored suite of CABHI’s Acceleration Services,
strategically crafted to streamline their innovation journey and pathway to market.

We’re excited to embark on the next phase of our innovation journey with CABHI, implementing
Class III Natural Product clinical studies and a concurrent Quality Improvement Pilot at Long Term Care facilities across Canada.

Together, we have the power to change the future of aging and brain health in Canada, and CABHI’s Fuel is going to help get us there!

Check out the full announcement to learn more: https://bit.ly/4rlSPDj